Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil in Chinese ED patients
NCT00668057Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2002
- Primary completion
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vardenafil in erectile dysfunction (ED) (6 arms), sponsored by Bayer. Primary endpoint: International Index of Erectile Function - Erectile Function Domain at 12 weeks. Started Dec 2002; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00668057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00668057.